Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Cash & Equivalents (2016 - 2025)

Ultralife has reported Cash & Equivalents over the past 16 years, most recently at $9.3 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $9.3 million for Q4 2025, up 36.34% from a year ago — trailing twelve months through Dec 2025 was $9.3 million (up 36.34% YoY), and the annual figure for FY2025 was $9.3 million, up 36.34%.
  • Cash & Equivalents for Q4 2025 was $9.3 million at Ultralife, up from $9.3 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for ULBI hit a ceiling of $15.9 million in Q3 2021 and a floor of $5.1 million in Q3 2022.
  • Median Cash & Equivalents over the past 5 years was $8.7 million (2025), compared with a mean of $9.1 million.
  • Biggest five-year swings in Cash & Equivalents: surged 123.64% in 2021 and later crashed 68.14% in 2022.
  • Ultralife's Cash & Equivalents stood at $8.4 million in 2021, then crashed by 39.96% to $5.1 million in 2022, then skyrocketed by 103.48% to $10.3 million in 2023, then tumbled by 33.31% to $6.9 million in 2024, then surged by 36.34% to $9.3 million in 2025.
  • The last three reported values for Cash & Equivalents were $9.3 million (Q4 2025), $9.3 million (Q3 2025), and $10.9 million (Q2 2025) per Business Quant data.